Mihic T, Fairbairn N, Nolan S, Dagenais R, Quon B, Socías ME Use of buprenorphine/naloxone in an adult with cystic fibrosis Can J Hosp Pharm PubMed

Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs CJEM PubMed

Brooks O, Ng JCY, Ickowicz S Outpatient rapid titration of slow release oral morphine for the treatment of opioid use disorder in a Canadian setting: a case series J Addict Med PubMed

Argento E, Omene E, Jaeger AH, Kertes A, Mitchell KA, Necyk C, Thielking P, Lewis EC Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy Front Neurosci PubMed

Hong R, Brar R, Fairbairn N Supporting self-isolation for COVID-19 with "risk mitigation" prescribing and housing supports for people who use drugs: a case report J Addict Med PubMed

Shearer D, Young S, Fairbairn N, Brar R Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series Drug Alcohol Rev PubMed

James H, Nolan S, Fairbairn N Rapid induction of buprenorphine/naloxone from methadone using a micro-dosing approach for opioid use disorder treatment in an inpatient setting: a case report UBC Med J Link

Milden J, Dickhout P, Nolan S Hospital-based buprenorphine/naloxone initiation in a patient with limited communication abilities: a case report J Addict Med PubMed

Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series J Addict Med PubMed

Bach P, Garrod E, Robinson K, Fairbairn N An acute care contingency management program for the treatment of stimulant use disorder: a case report J Addict Med PubMed